Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)
Latest Information Update: 08 Aug 2023
At a glance
- Drugs Duvelisib (Primary) ; Tucidinostat (Primary)
- Indications Follicular lymphoma; Peripheral T-cell lymphoma; T-cell lymphoma
- Focus Adverse reactions
- 08 Aug 2023 New trial record